News
-
-
PRESS RELEASE
EQS-Adhoc: Vonovia announces EUR 750 million convertible bond offering
Vonovia SE announces EUR 750 million convertible bond offering. The Bonds will be convertible into new or existing Ordinary Shares or repaid in cash, with exclusive offering to institutional investors outside the United States -
-
-
-
-
-
-
-
PRESS RELEASE
Press Release: Sanofi’s Cenrifki (tolebrutinib) approved in the EU as the first disability-targeting medicine for secondary progressive multiple sclerosis without relapses
Sanofi gains EU approval for Cenrifki (tolebrutinib) as the first disability-targeting medicine for secondary progressive multiple sclerosis without relapses, based on phase 3 studies. Cenrifki addresses SPMS disability progression